Summary
After oral administration of14C-labelled emepronium (150 mg) to two subjects, 1.8 and 3.9% of the radioactivity were recovered from the urine within 24 h, of which 50 and 56% respectively, were excreted during the first 6 h. 23 to 35% of the radioactivity in the urine consisted of emepronium metabolites. 25 mg of the cold compound was injected i.m. in 4 subjects; about 31% was excreted in the urine and about 45% in the faeces within 3 days, probably indicating extensive biliary excretion of unaltered drug. The half-life of emepronium in serum ranged from 1.5 to 2.25 h. The near point of accommodation, salivation and heart rate were compared with the serum concentration of emepronium in a randomized cross-over study in 4 subjects. The heart rate was increased significantly at serum concentrations of about 450 ng/ml, and the secretion of saliva was markedly decreased at about 250 ng/ml. The near point was affected only at the highest serum concentrations.
Similar content being viewed by others
References
Eksborg, S., Persson, B.-A., Vessman, J., Enell, B.: Determination of a quaternary ammonium compound, emepronium bromide (Cetiprin®) in human urine by an ion pair extraction method. J. pharm. Sci.60, 475–477 (1971)
Gröningsson, K., Hammar, C-G., Molin, L., Vessman, J.: unpublished (1972)
Hansson, E., Schmiterlöw, C.G.: Biological fate of14C-labelled ethyl (3.3-diphenyl-l-methyl-propyl) dimethylammoniumbromide, Cetiprin®, a monoquaternary ammonium compound. Acta Pharmacol. (Kbh.)18, 183–190 (1961)
Sundwall, A., Uthne, K., Vessman, J.: Metabolic disposition of emepronium in the dog with a note on the relationship between plasma concentration and effect. Acta pharmacol. (Kbh.)29, 385–401 (1971)
Vessman, J., Strömberg, S., Rietz, G.: Gas chromatography and electron capture detection of benzophenone formed by chromic acid oxidation. II. Determination of emepronium (Cetiprin®) a quaternary ammonium compound in serum. Acta pharm. suecica7, 363–372 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sundwall, A., Vessman, J. & Strindberg, B. Fate of emepronium in man in relation to its pharmacological effects. Eur J Clin Pharmacol 6, 191–195 (1973). https://doi.org/10.1007/BF00558285
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558285